However, Wang et al. recently demonstrated the capacity of melatonin to impede prostate cancer metastasis through suppressing MMP-13 and thus inhibiting migratory and invasive capacities of prostate cancer cells in vitro and in vivo [65]. Here, MMP13 is linked to prostate carcinoma.